CLEC10A and germ cell tumor: A strong association of HERV-K (HML-2) antibodies and the clinical manifestation of the disease and therapy success suggests that HERV-K (HML-2) antibodies seem to have an important diagnostic value as well as an indicator of chemotherapy success in germ cell tumors (Kleiman et al., 2004).